Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/14/10  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Richard A. Guarino

Wrong Dr. Richard A. Guarino?
 
Background

Employment History

  • President
    Oxford Pharmaceutical Resources , Inc.
  • President
    Oxford Pharmaceutical Services Inc
  • President and Chief Executive Officer
    Oxford Research International Corp.
  • Vice President and Medical Director
    Revlon Healthcare Group
  • Director of Clinical Research
    Sandoz Inc

Board Memberships and Affiliations

Education

  • MD
  • M.D.
17 Total References
Web References
Dr. Richard A. Guarino, ...
www.hum-molgen.org, 14 Jan 2010 [cached]
Dr. Richard A. Guarino, President, Oxford Pharmaceutical Resources, Inc.
Richard A. Guarino, MD; ...
www.cfpa.com, 20 Jan 2007 [cached]
Richard A. Guarino, MD; President, Oxford Pharmaceutical Resources, Inc.
Dr. Richard A. Guarino is President of Oxford Pharmaceutical Resources, Inc., a Consulting Clinical and Regulatory Organization specializing in the planning, implementing and submitting INDs, NDAs, in the CTDs format. Dr, Guarino has 35 years of experience in new drug applications, marketing launches, pharmaceutical and product advertising, and FDA Liaison. He was formerly the President and CEO of Oxford Research International Corp. one of the largest CRO's in the United States. Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc, (Novartis) and held the position of Vice President/Medical Director at Revlon Healthcare Group. He has been acclaimed for his book, New Drug Approval Process, now in its 5th edition. It is the first book ever written to guide and recommend ways to expedite the new drug approval process while following all the requirements of the US Code of Federal Regulations, EU Directives and ICH Guidelines.
Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Sovereign Military Hospitaller Order of Saint John of Jerusalem of Rhodes and of Malta American Association, USA Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).
By Richard Guarino, Oxford ...
www.informahealthcarebooks.com, 1 June 2009 [cached]
By Richard Guarino, Oxford Pharmaceutical Resources, Totowa, New Jersey, USA
...
Richard Guarino is President of Oxford Pharmaceuticals, Inc., and was the former CEO of Oxford Research International Corp. He is the editor of Informa Healthcare's Fourth Edition of New Drug Approval Process, the first book to guide and recommend ways to expedite global new drug approval processes while also following meeting federal and industry requirements. Dr. Guarino is a member of the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Columbus Foundation, Drug Information Association, Association of Clinical Research Professionals, and the Academy of Pharmaceutical Physicians and Investigators.
Dr. Richard A. Guarino; President, ...
www.hum-molgen.org, 20 Nov 2007 [cached]
Dr. Richard A. Guarino; President, Oxford Pharmaceutical Resources, Inc.
Richard A. Guarino, M.D. is President of Oxford Pharmaceutical Resources, Inc. a consulting organization specializing in the planning, implementing and submitting of INDs, NDAs and CTDs.Dr. Guarino also has 25 years of experience in new drug applications, in marketing launches, advertising, and FDA liaison.
Dr. Guarino was formerly the President and CEO of Oxford Research International Corp. one of the largest CROs in the United States.Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc., now Novartis, and held the position of Vice President/Medical Director at Revlon Healthcare Group.He has been acclaimed for his book, New Drug Approval Process, now in its 4th edition.It is the first book ever written to guide and recommend ways to expedite global new drug approval process while following all the requirements of the Code of Federal Regulations and EU Directives.
Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Columbus Foundation, Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).
Richard A. Guarino, MD; ...
www.cfpa.com, 20 Jan 2007 [cached]
Richard A. Guarino, MD; President, Oxford Pharmaceutical Resources, Inc.
Dr. Richard A. Guarino is President of Oxford Pharmaceutical Resources, Inc., a Consulting Organization specializing in the planning, implementing and submitting of INDs, NDAs, in CTDs format. Dr, Guarino has 30 years of experience in new drug applications, marketing launches, advertising, and FDA Liaison. He was formerly the President and CEO of Oxford Research International Corp. one of the largest CRO's in the United States. Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc, (Novartis) and held the position of Vice President/Medical Director at Revlon Healthcare Group. He has been acclaimed for his book, New Drug Approval Process, now in its 5th edition. It is the first book ever written to guide and recommend ways to expedite the new drug approval process while following all the requirements of the US Code of Federal Regulations, EU Directives and ICH Guidelines.
Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Sovereign Military Hospitaller Order of Saint John of Jerusalem of Rhodes and of Malta American Association, USA Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).
Other People with the name "Guarino":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304